Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEANS: Bevacizumab with Carboplatin and Gemcitabine in Platinum-Sensitive Recurrent Ovarian Cancer
NCT00434642Phase 3Completed
- Sponsor
- Genentech
- Start
- Apr 2007
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in ovarian cancer, primary peritoneal carcinoma (PPC), fallopian tube carcinoma (PFTC), sponsored by Genentech. Started Apr 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancerprimary peritoneal carcinoma (PPC)fallopian tube carcinoma (PFTC)
Beyond the preview
Go deeper on NCT00434642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434642.